Blocklisting Interim Review

RNS Number : 7576E
Hutchison China Meditech Limited
29 December 2009
 





Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)


Blocklisting Six Monthly Return



LondonTuesday, 29 December 2009: Chi-Med announces the following blocklisting six monthly return: 


1.

Name of applicant:



Hutchison China MediTech Limited

2.

Name of scheme:



Hutchison China MediTech Limited Share Option Scheme


3.

Period of return:    



From 29 June 2009 to 28 December 2009


4.

Balance under scheme from previous return:



2,543,553 ordinary shares of US$1 each


5.

The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return: 



Nil

6.

Number of securities issued/allotted under scheme during period:


50,000 ordinary shares of US$1 each





7.

Balance under scheme not yet issued/allotted at end of the period:



2,493,553 ordinary shares of US$1 each

8.

Number and class of securities originally listed and the date of admission:



2,560,606 ordinary shares of US$1 each admitted on 26 June 2007

9.

Total number of securities in issue at the end of the period:


51,279,174 ordinary shares of US$1 each.





Name of contact:



Christian Hogg

Address of contact:



21/F., Hutchison House, 10 Harcourt RoadHong Kong


Telephone number of contact:



+852 2121 8200




Ends







Enquiries


  Chi-Med

  Christian Hogg, CEO

Telephone: +852 2121 8200



  Citigate Dewe Rogerson

  Anthony Carlisle

  David Dible

Telephone: +44 (0) 20 7638 9571

+44 (0) 7973 611 888

+44 (0) 7967 566 919




About Chi-Med


Chi-Med is the holding company of a pharmaceutical and healthcare group based primarily in China and was admitted to trading on the Alternative Investment Market of the London Stock Exchange in May 2006. It is focused on researching, developing, manufacturing, and selling pharmaceuticals, health supplements and other consumer health and personal care products derived from Traditional Chinese Medicine and botanical ingredients. 


Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRGGMZZLLFGLZG
UK 100

Latest directors dealings